Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2025-12-29 @ 2:26 AM
Study NCT ID:
NCT04648761
Status:
UNKNOWN
Last Update Posted:
2023-01-18
First Post:
2020-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Individualized Titration of Biologics in Severe Asthma
Sponsor:
Bispebjerg Hospital
Organization:
Study Overview
Official Title:
OPTIMAL - Individualized Titration of Biologics in Severe Asthma
Status:
UNKNOWN
Status Verified Date:
2023-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPTIMAL
Brief Summary:
OPTIMAL is a non-inferiority, open label randomized clinical trial thats investigates a titration algorithm for anti IL 5 biologics in severe asthma.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: